Research reveals unique guaiane-type sesquiterpenoids with potential cholinesterase inhibitory activity, indicating their role as neurological agents.
Under the guidance of the approach that integrates molecular networking, MS-DIAL and self-built database, 11 undescribed guaiane-type sesquiterpenoids (1–11) along with four known analogs (12–15) were targeted and isolated from Daphne aurantiaca. Among these, dapurant A–B (1–2) were unusual guaiane-type sesquiterpenoid dimers consisting of two guaiane-type sesquiterpenoids with different ring skeletons, and dapurant C–D (3–4) represented rare chlorinated guaiacane-type sesquiterpenoids. Their chemical structures and configurations were established via NMR spectroscopy analysis, computer-assisted structure elucidation methods, density functional theory (DFT) NMR calculations with suitable analysis methods (custom DP4+ analysis, CP3 analysis, MAEΔΔδ), DU8+, electron-capture detector, detection (EC)D calculations, Rh2(OCOCF3)4-induced ECD analysis along with semisynthesis method. The network pharmacology analysis prompted us to explore the cholinesterase inhibitory activity and anti-Aβ aggregation activity of the isolates in vitro and in silico. The bioactivity evaluation results highlighted the prospects of 1, 13, and 14 as novel categories of neurological agents.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: